Avelox and Levaquin Lawsuits Filed Over Nerve Damage From Fluoroquinolone Antibiotics

Posted
by Charles Miller

Lawsuits against the manufacturers of the fluoroquinolone antibiotics Avelox and Levaquin have been filed in California on behalf of patients who were diagnosed with a type of nerve damage known as peripheral neuropathy after taking these drugs. Patients who were prescribed these or other fluoroquinolones and have been diagnosed with peripheral neuropathy—or who have developed symptoms of chronic nerve damage—may also be eligible to file a lawsuit.

Fluoroquinolones (or FQ antibiotics) are one of the most commonly prescribed types of antibiotic drugs in the U.S., used by more than 23 million patients in 2011 alone. Cipro, Avelox, and Levaquin are the most commonly prescribed brands of fluoroquinolone antibiotics.

Fluoroquinolones have been approved by the Food and Drug Administration to treat a wide variety of conditions, including pneumonia, sinus infections, urinary tract infections (UTI), chronic bronchitis, skin infections, chronic bacterial prostatitis, acute pyelonephritis, and other types of infections.

FDA Warning Links Fluoroquinolones and Peripheral Neuropathy

In 2013, the FDA issued a warning about the link between fluoroquinolones and peripheral neuropathy following the publications of several studies that examined the side effects risk of these antibiotic drugs. The FDA required the makers of all fluoroquinolones to include a warning on the labels of these drugs to warn patients about their risk of serious and potentially irreversible nerve damage that can result from taking these antibiotics.

According to the FDA’s warning about fluoroquinolones, nerve damage from peripheral neuropathy may occur rapidly after a patient starts taking drugs and can cause permanent injuries after just a short time. The agency warned about symptoms that could be an early sign of nerve damage from peripheral neuropathy, “including pain, burning, tingling, numbness, and/or weakness or other alterations of sensation including light touch, pain, temperature, position sense, and vibratory sensation.”

Lawsuits Over Fluoroquinolone Nerve Damage

Lawsuits against the manufacturer of Avelox (Bayer Pharmaceuticals) and Levaquin (Johnson & Johnson) were filed in Fall 2014 by patients who developed nerve damage after taking these drug. Due to the link between fluoroquinolone antibiotics and peripheral neuropathy and the millions of patients who have taken fluoroquinolones, legal experts believe that many additional patients could file lawsuits this year.

If you or a loved one were diagnosed with peripheral neuropathy after being prescribed FQ antibiotics such as Cipro, Avelox, and Levaquin, you may be eligible to file a lawsuit against the manufacturer of these drugs. Patients who have experienced symptoms of nerve damage in the hands, arms, legs, or feet that could be signs of peripheral neuropathy—including pain, numbness, tingling, burning, or weakness—may also qualify to file a lawsuit. The first step in finding out whether you qualify for a lawsuit is to speak with an attorney with the experience to handle pharmaceutical litigation cases such as those involving Cipro, Avelox, Levaquin, and other FQ antibiotic drugs.

The lawyers at Heygood, Orr & Pearson have filed countless lawsuits on behalf of patients who were injured by defective drugs or other medical products. Our law firm has filed lawsuits on behalf of patients who have been injured by overdoses caused by the fentanyl pain patch or other prescription opioid painkillers and many other medications. Our attorneys have achieved verdicts and settlements on behalf of our clients totaling more than $200 million—including settlements of more than $50 in 2010 alone.

To learn more about filing a lawsuit involving peripheral neuropathy caused by Ciprio, Avelox, Levaquin or other FQ antibiotics, contact the attorneys at Heygood, Orr & Pearson for a free legal consultation about your case. You can reach us by calling toll-free at 1-877-446-9001, or by following the link to our free case evaluation form on this website.